Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galenika A.D.filedCriticalGalenika A.D.
Priority to YU14403ApriorityCriticalpatent/YU14403A/en
Publication of YU14403ApublicationCriticalpatent/YU14403A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Saccharide Compounds
(AREA)
Abstract
The invention relates to both the new method and the use of 2-ß-D-ribofuranosylthiazole-4 carboxiamide and derivatives thereof, primarily 5'-O-esters, for production of pharmaceutical products for healing and prevention of systemic autoimmune disorders, primarily multiplex sclerosis.
YU14403A2003-02-252003-02-25New use of compounds
YU14403A
(en)
Pharmaceutical formulation for the efficient administration of apomorphine, 6ar-(-)-n-propyl-norapomorphine and their derivatives and pro-drugs thereof